Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19NCT04347239CytoDyn, Inc.Phase 2Completed2021-10-24Actual
Follow-up Study of AAV-Mediated Gene Transfer (UX111; Previously Known as ABO-102) for MPS Type IIIANCT04360265RAREPhase 3Enrolling by invitation2027-08Estimated
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH CirrhosisNCT04365868GALTPhase 2, Phase 3Terminated2025-03-11Actual
INB03 for the Treatment of Pulmonary Complications From COVID-19NCT04370236INMBPhase 2, Phase 3Terminated2021-10-13Actual
Phase 3 Trial of Pamrevlumab or Placebo With Systemic Corticosteroids in Participants With Non-ambulatory Duchenne Muscular Dystrophy (DMD)NCT04371666Kyntra BioPhase 3Terminated2023-02-13Actual
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)NCT04374136ALECPhase 3Terminated2025-09-01Actual
A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory EpilepsyNCT04378075PTC TherapeuticsPhase 2, Phase 3Terminated2023-03-18Actual
A Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 as Addition to Investigator's Choice of Standard of Care Therapy, in Patients With Coronavirus Disease 19 (COVID-19)NCT04379271Immunic AGPhase 2, Phase 3Completed2021-01-12Actual
Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-GuerinNCT04387461CGONPhase 2Completed2023-03-07Actual
Combination Immunotherapy Plus Standard-of-Care Chemotherapy Versus Standard-of-Care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic CancerNCT04390399IBRXPhase 2Active not recruiting2025-10-13Actual
ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19NCT04393038ABVXPhase 2, Phase 3Terminated2021-03-05Actual
A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion GeneNCT04395677NUVBPhase 2Active not recruiting2024-06-07Actual
Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary FibrosisNCT04396756PLRXPhase 2Completed2023-02-01Actual
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19NCT04401475EDSAPhase 2, Phase 3Suspended2024-12Estimated
PH94B in the Treatment of Adjustment Disorder With AnxietyNCT04404192VTGNPhase 2Completed2022-12-14Actual
D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)NCT04411199PYPDPhase 3Completed2025-04-14Actual
Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19NCT04412668ATYRPhase 2Completed2020-10-23Actual
Study of VIR-2218 With or Without Pegylated Interferon Alpha-2a for Treatment of Chronic Hepatitis B Virus InfectionNCT04412863VIRPhase 2Completed2024-03-25Actual
A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.NCT04414475KPTIPhase 2Recruiting2028-01Estimated
Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal MelanomaNCT04417530Aura BiosciencesPhase 2Completed2024-04-22Actual
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)NCT04419558Kyntra BioPhase 3Terminated2023-09-04Actual
Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic TreatmentNCT04421456Jazz PharmaceuticalsPhase 2Terminated2022-03-16Actual
Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDSNCT04429555MediciNovaPhase 2Completed2022-06-30Actual
A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)NCT04433585NKTRPhase 2Completed2023-01-10Actual
Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction TherapyNCT04436029Cartesian TherapeuticsPhase 2Completed2022-02-18Actual
A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)NCT04439071PTC TherapeuticsPhase 2, Phase 3Terminated2022-07-20Actual
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaNCT04442022KPTIPhase 2, Phase 3Active not recruiting2026-12Estimated
Crossover Trial of AD036 in Obstructive Sleep ApneaNCT04445688ApnimedPhase 2Completed2020-12-01Actual
Long-Term Safety of ARQ-154 Foam in Subjects With Seborrheic DermatitisNCT04445987ARQTPhase 2Completed2022-11-19Actual
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117ExelixisPhase 3Active not recruiting2024-04-19Actual

Primary completion marks the end of data collection for the main study measures, not a results publication date.